Newslocker Logo
16-03-2025 20:53 via medpagetoday.com

Add-On Metformin Promising in ER-Positive Endometrial Cancer

(MedPage Today) -- Adding metformin to letrozole and abemaciclib (Verzenio) was tied to deep responses and prolonged progression-free survival (PFS) in some patients with recurrent estrogen receptor (ER)-positive endometrial cancer, per a phase...
Read more »